0001209191-15-040806.txt : 20150508 0001209191-15-040806.hdr.sgml : 20150508 20150508195258 ACCESSION NUMBER: 0001209191-15-040806 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150507 FILED AS OF DATE: 20150508 DATE AS OF CHANGE: 20150508 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HYPERION THERAPEUTICS INC CENTRAL INDEX KEY: 0001386858 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 611512713 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 400 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 650-745-7802 MAIL ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 400 CITY: BRISBANE STATE: CA ZIP: 94005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Santel Donald J CENTRAL INDEX KEY: 0001293630 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35614 FILM NUMBER: 15848544 MAIL ADDRESS: STREET 1: 5000 SHORELINE COURT, SUITE 101 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-05-07 1 0001386858 HYPERION THERAPEUTICS INC HPTX 0001293630 Santel Donald J C/O HYPERION THERAPEUTICS, INC. 2000 SIERRA POINT PARKWAY, SUITE 400 BRISBANE CA 94005 1 1 0 0 CEO & President Common Stock 2015-05-07 4 U 0 2306 46.00 D 0 D Common Stock 2015-05-07 4 U 0 10164 46.00 D 0 I By Donald J. Santel and Kelly L. McGinnis, Trust UA. dated 12/18/08 FBO Margaret Cate Santel Common Stock 2015-05-07 4 D 0 53875 46.00 D 0 D Common Stock 2015-05-07 4 D 0 292057 46.00 D 0 D Stock Option (Right to Buy) 1.28 2015-05-07 4 D 0 303133 46.00 D 2019-11-02 Common Stock 303133 0 D Stock Option (Right to Buy) 4.08 2015-05-07 4 D 0 6648 46.00 D 2021-04-14 Common Stock 6648 0 D Stock Option (Right to Buy) 7.31 2015-05-07 4 D 0 88547 46.00 D 2022-04-15 Common Stock 88547 0 D Stock Option (Right to Buy) 24.46 2015-05-07 4 D 0 143000 46.00 D 2023-04-14 Common Stock 143000 0 D Stock Option (Right to Buy) 26.74 2015-05-07 4 D 0 111000 46.00 D 2024-03-10 Common Stock 111000 0 D Stock Option (Right to Buy) 25.97 2015-05-07 4 D 0 70000 46.00 D 2025-02-08 Common Stock 70000 0 D Stock Option (Right to Buy) 327.95 2015-05-07 4 D 0 169 0.00 D 2017-09-03 Common Stock 169 0 D Shares that were tendered pursuant to the offer from Horizon Pharma plc ("Horizon") to acquire shares of the issuer. Restricted stock units covering shares of issuer common stock that will be cashed-out and cancelled in connection with the merger of the issuer and Horizon (the "Merger"). Shares that are being acquired by Horizon in the Merger. Options to acquire shares of issuer common stock that will be cashed-out and cancelled in connection with the Merger. Options to acquire shares of issuer common stock that will be cancelled for no consideration in connection with the Merger. /s/ Sally Brammell, Attorney-in-Fact 2015-05-08